Thank you, Michelle. AAPS PK Methodology Discussion Group welcome any scientific-centric presentations. Please reach out Dr. Mark Ma (Mark Ma <[email protected]>) who is the founder of the discussion group directly to see whether it fits the group interest. Regards, Sophia
------------------------------
Xiaohui Xu Ph.D.
Director
Daiichi Sankyo
Basking Ridge NJ
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------
Original Message:
Sent: 01-09-2025 17:36
From: Michele Fiscella
Subject: AAPS PK Assay Methodology Group Oct Meeting minutes
Hi,
I just read the document attached in the
I would be happy to share my experience in AAV-based GT BioA support for PD, PK, BD, immunogenicity (cellular and humoral).
Thanks
Michele Fiscella (he, him)
Vice President
Translational & Bioanalytical Sciences
REGENXBIO Inc.
Rockville, Maryland 20850
(e) [email protected]
www.regenxbio.com
Original Message:
Sent: 1/8/2025 2:43:00 PM
From: Xiaohui Xu
Subject: AAPS PK Assay Methodology Group Oct Meeting minutes
Dear All:
AAPS PK Methodology Group October meeting captured Pharmacokinetic strategy for AVV preclinical and clinical studies and BA challenges. See attachment for detailed information
------------------------------
Xiaohui Xu Ph.D.
Director
Daiichi Sankyo
Basking Ridge NJ
[email protected]
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------